Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion type Assertion NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_head.
- NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_provenance.
- NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion evidence source_evidence_literature NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_provenance.
- NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion SIO_000772 18480833 NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_provenance.
- NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion wasDerivedFrom befree-2016 NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_provenance.
- NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion wasGeneratedBy ECO_0000203 NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_provenance.